Schubert & Co’s Pediatrix Medical MD Stock Holding History

Schubert & Co’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31	Closed	-$463	–	904
2023 Q1	$463	Buy	31 +2	+7%	+$30	﹤0.01%	1434
2022 Q4	$431	Buy	29 +14	+93%	+$228	﹤0.01%	1422
2022 Q3	$0	Buy	15 +8	+114%	+$161	﹤0.01%	1490
2022 Q2	$0	Buy	7 +6	+600%	+$122	﹤0.01%	1533
2022 Q1	$0	Sell	1 -1	-50%	-$24	﹤0.01%	1229
2021 Q4	$0	Buy	+2	New	+$54	﹤0.01%	1168

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Schubert & Co's MD Position: Q2 2023 in Review

Schubert & Co sold out of Pediatrix Medical (MD) in Q2 2023, closing a stake of 31 shares — an estimated $463 sold.

Schubert & Co first reported a position in MD in Q4 2021 and held it in 6 quarters. The position peaked at $463 in Q1 2023. 215 funds tracked by Wall St. Rank hold MD as of Q2 2023.

Schubert & Co reported no remaining Pediatrix Medical position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 31 Pediatrix Medical shares in Q2 2023, an estimated $463.
Schubert & Co first reported a position in Pediatrix Medical in Q4 2021 and held it in 6 quarters.
Schubert & Co's Pediatrix Medical position peaked at $463 in Q1 2023.
215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.